Aurobindo Pharma

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue2,4392,6862,4862,7363,023
Expenses2,0021,9292,0602,2262,336
EBITDA522.24855.90517.26612.26812.82
EBIT462.37789.22457.63546.47748.47
Profit Before Tax412.99757.45443.99545.87687.22
Net Profit298.82644.80335.95415.74623.78
Financial Ratios
Operating Profit Margin21.32%36.09%22.64%24.48%30.51%
Net Profit Margin13.82%27.19%13.45%14.34%23.42%
Earning Per Share (Diluted)5.1010.225.747.1010.65
Dividends Per Share3.000.000.000.001.50
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ